Skip to main content
SpringerLink
Log in

Dehydroepiandrosterone (DHEA) and its Sulfate (DHEAS) in Critical Illness

  • Conference paper
Intensive Care Medicine

  • 331 Accesses

Abstract

Dehydroepiandrosterone (DHEA) is the most abundant circulating hormone in the human body and can be converted to either androgens or estrogens. It is readily conjugated to its sulfate ester, DHEAS, and they are designated as DHEA(S) here when used together [1]. DHEA has received considerable attention in the lay and scientific press for its anti-aging effects and as mediator of several diseases. A number of reports have suggested that DHEAS levels are inversely related to cardiovascular disease and mortality, but findings have not been consistent [2]. In the USA, DHEA is currently available as an over-the counter drug; as a precursor of testosterone, entitled as a “fountain of youth” [3] or “the last elixir”.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ebeling P, Koivisto VA (1994) Physiological importance of dehydroepiandrosterone. Lancet 343: 1479–1481

    Article  PubMed  CAS  Google Scholar 

  2. Trivedi DP, Khaw KT (2001) Dehydroepiandrosterone sulfate and mortality in elderly men and women. J Clin Endocrinol Metab 86: 4171–4177

    Article  PubMed  CAS  Google Scholar 

  3. Baulieu EE (1996) Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metab 81: 3147–3151

    Article  PubMed  CAS  Google Scholar 

  4. Arlt W, Callies F, van Vlijmen JC, et al (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341: 1013–1020

    Article  PubMed  CAS  Google Scholar 

  5. Oberbeck R, Dahlweid M, Koch R, et al (2001) Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Crit Care Med 29: 380–384

    Article  PubMed  CAS  Google Scholar 

  6. Angele MK, Catania RA, Ayala A, Cioffi WG, Bland KI, Chaudry IH (1998) Dehydroepiandrosterone: an inexpensive steroid hormone that decreases the mortality due to sepsis following trauma-induced hemorrhage. Arch Surg 133: 1281–1288

    Article  PubMed  CAS  Google Scholar 

  7. Araneo BA, Shelby J, Li GZ, Ku W, Daynes RA (1993) Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch Surg 128: 318–325

    Article  PubMed  CAS  Google Scholar 

  8. Ben Nathan D, Padgett DA, Loria RM (1999) Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity. J Med Microbiol 48: 425–431

    Article  Google Scholar 

  9. Schurr MJ, Fabian TC, Croce MA, Varnavas LE, Proctor KG (1997) Dehydroepiandrosterone, an endogenous immune modulator, after traumatic shock. Shock 7: 55–59

    Article  PubMed  CAS  Google Scholar 

  10. Loria RM, Inge TH, Cook SS, Szakal AK, Regelson W (1988) Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone ( DHEA ). J Med Virol 26: 301–314

    Google Scholar 

  11. Jarrar D, Kuebler JF, Wang P, Bland KI, Chaudry IH (2001) DHEA: a novel adjunct for the treatment of male trauma patients. Trends Mol Med 7: 81–85

    Article  PubMed  CAS  Google Scholar 

  12. Parker LN (1991) Control of adrenal androgen secretion. Endocrinol Metab Clin North Am 20: 401–421

    PubMed  CAS  Google Scholar 

  13. van Weerden WM, Bierings HG, van Steenbrugge GJ, de Jong FH, Schroder FH (1992) Adrenal glands of mouse and rat do not synthesize androgens. Life Sci 50: 857–861

    Article  PubMed  Google Scholar 

  14. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H (1992) Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75: 1002–1004

    Article  PubMed  CAS  Google Scholar 

  15. Wolkersdorfer GW, Lohmann T, Marx C, et al (1999) Lymphocytes stimulate dehydroepiandrosterone production through direct cellular contact with adrenal zona reticularis cells: a novel mechanism of immune-endocrine interaction. J Clin Endocrinol Metab 84: 4220–4227

    Article  PubMed  CAS  Google Scholar 

  16. Regelson W, Kalimi M (1994) Dehydroepiandrosterone (DHEA) - the multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? Ann NY Acad Sci 719: 564–575

    Google Scholar 

  17. McLachlan JA, Serkin CD, Bakouche O (1996) Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J Immunol 156: 328–335

    PubMed  CAS  Google Scholar 

  18. Regelson W, Loria R, Kalimi M (1994) Dehydroepiandrosterone (DHEA) - the “mother steroid”. I. Immunologic action. Ann NY Acad Sci 719: 553–563

    Google Scholar 

  19. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY (1993) Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 150: 5219–5230

    Google Scholar 

  20. Danenberg HD, Alpert G, Lustig S, Ben Nathan D (1992) Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob Agents Chemother 36: 2275–2279

    Article  PubMed  CAS  Google Scholar 

  21. Parker LN, Levin ER, Lifrak ET (1985) Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 60: 947–952

    Article  PubMed  CAS  Google Scholar 

  22. Wade CE, Lindberg JS, Cockrell JL, et al (1988) Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J Clin Endocrinol Metab 67: 223–227

    Article  PubMed  CAS  Google Scholar 

  23. Semple CG, Gray CE, Beastall GH (1987) Adrenal androgens and illness. Acta Endocrinol (Copenh) 116: 155–160

    CAS  Google Scholar 

  24. Lephart ED, Baxter CR, Parker CR, Jr (1987) Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab 64: 842–848

    Article  PubMed  CAS  Google Scholar 

  25. Luppa P, Munker R, Nagel D, Weber M, Engelhardt D (1991) Serum androgens in intensive-care patients: correlations with clinical findings. Clin Endocrinol (Oxf) 34: 305–310

    Article  CAS  Google Scholar 

  26. Spratt DI, Longcope C, Cox PM, Bigos ST, Wilbur-Welling C (1993) Differential changes in serum concentrations of androgens and estrogens (in relation with cortisol) in postmenopausal women with acute illness. J Clin Endocrinol Metab 76: 1542–1547

    Article  PubMed  CAS  Google Scholar 

  27. Bornstein SR, Wolkersdorfer GW, Tauchnitz R, Preas HL, Chrousos GP, Suffredini AF (2000) Plasma dehydroepiandrosterone levels during experimental endotoxemia and anti-inflammatory therapy in humans. Crit Care Med 28: 2103–2106

    Article  PubMed  CAS  Google Scholar 

  28. Schuld A, Mullington J, Friess E, et al (2000) Changes in dehydroepiandrosterone ( DHEA) and DHEA-sulfate plasma levels during experimental endotoxinemia in healthy volunteers. J Clin Endocrinol Metab 85: 4624–4629

    Google Scholar 

  29. Folan MM, Stone RA, Pittenger AL, Stoffel JA, Hess MM, Kroboth PD (2001) Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients. Crit Care Med 29: 965–970

    Article  PubMed  CAS  Google Scholar 

  30. Beishuizen A, Thijs LG (2001) Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab 15: 513–531

    Article  PubMed  CAS  Google Scholar 

  31. Beishuizen A, Vermes I, Hylkema BS, Haanen C (1999) Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 353: 1675–1676

    Article  PubMed  CAS  Google Scholar 

  32. Parker CR Jr, Slayden SM, Azziz R, et al (2000) Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85: 48–54

    Article  PubMed  CAS  Google Scholar 

  33. Vermes I, Beishuizen A, Hampsink RM, Haanen C (1995) Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 80: 1238–1242

    Article  PubMed  CAS  Google Scholar 

  34. Beishuizen A, Thijs LG, Vermes I (2002) Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit Care 6: 434–438

    Article  PubMed  Google Scholar 

  35. van den Berghe G, de Zegher F, Wouters P, et al (1995) Dehydroepiandrosterone sulphate in critical illness: effect of dopamine Clin Endocrinol (Oxf) 43: 457–463

    Article  Google Scholar 

  36. Straub RH, Konecna L, Hrach S, et al (1998) Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83: 2012–2017

    Article  PubMed  CAS  Google Scholar 

  37. Mastorakos G, Chrousos GP, Weber JS (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77: 1690–1694

    Article  PubMed  CAS  Google Scholar 

  38. Gennari R, Alexander JW (1997) Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis. Crit Care Med 25: 1207–1214

    Article  PubMed  CAS  Google Scholar 

  39. Araneo B, Daynes R (1995) Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endocrinology 136: 393401

    Google Scholar 

  40. Jarrar D, Wang P, Cioffi WG, Bland KI, Chaudry IH (2000) Mechanisms of the salutary effects of dehydroepiandrosterone after trauma-hemorrhage: direct or indirect effects on cardiac and hepatocellular functions? Arch Surg 135: 416–422

    Article  PubMed  CAS  Google Scholar 

  41. Hunt PJ, Gurnell EM, Huppert FA, et al (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison’s disease in a randomized, double blind trial. J Clin Endocrinol Metab 85: 4650–4656

    Article  PubMed  CAS  Google Scholar 

  42. Callies F, Fassnacht M, van Vlijmen JC, et al (2001) Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol Metab 86: 1968–1972

    Article  PubMed  CAS  Google Scholar 

  43. Van den Berghe G, de Zegher F, Bouillon R (1998) Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83: 18271834

    Google Scholar 

Download references

Authors
  1. A. Beishuizen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. B. J. Groeneveld
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent MD, PhD, FCCM, FCCP (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Beishuizen, A., Groeneveld, A.B.J. (2003). Dehydroepiandrosterone (DHEA) and its Sulfate (DHEAS) in Critical Illness. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-5548-0_82

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-5548-0_82

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-5550-3

  • Online ISBN: 978-1-4757-5548-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation